<DOC>
	<DOC>NCT00331175</DOC>
	<brief_summary>The purpose of this trial is to evaluate the safety and tolerability of single escalating doses of Peptide YY3-36 and to determine effects on food intake and serum hormones when administered by intravenous infusion to otherwise healthy overweight adult subjects.</brief_summary>
	<brief_title>Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>BMI 2735 kg/m2 Women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>